While there is literature to suggest that norepinephrine increases VEGF levels in tumor models [17, 18], others have reported that isoproterenol (a β-adrenergic receptor agonist) can reduce VEGF levels in the retina [19]. This evidence concerns the gene VEGFA and neoplasm.